Semi-Annual Consolidated Balance Sheet

BrightPath Biotherapeutics Co., Ltd. - Filing #7585095

Concept As at
2022-09-30
As at
2022-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,913,913,000 JPY
2,305,026,000 JPY
Other
136,561,000 JPY
374,437,000 JPY
Current assets
2,050,555,000 JPY
2,696,050,000 JPY
Non-current assets
Property, plant and equipment
16,558,000 JPY
24,918,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
0 JPY
0 JPY
Investments and other assets
50,234,000 JPY
50,234,000 JPY
Investments and other assets
Non-current assets
66,792,000 JPY
75,152,000 JPY
Assets
2,117,347,000 JPY
2,771,202,000 JPY
Liabilities
Current liabilities
Income taxes payable
8,214,000 JPY
38,817,000 JPY
Other
44,564,000 JPY
143,925,000 JPY
Current liabilities
54,628,000 JPY
184,655,000 JPY
Non-current liabilities
Asset retirement obligations
22,511,000 JPY
22,465,000 JPY
Other
0 JPY
0 JPY
Non-current liabilities
55,922,000 JPY
55,071,000 JPY
Liabilities
110,550,000 JPY
239,727,000 JPY
Net assets
Shareholders' equity
Share capital
243,671,000 JPY
6,700,382,000 JPY
Capital surplus
2,552,205,000 JPY
6,683,967,000 JPY
Retained earnings
-810,742,000 JPY
-10,875,815,000 JPY
Treasury shares
0 JPY
JPY
Shareholders' equity
1,985,134,000 JPY
2,508,534,000 JPY
Share acquisition rights
21,663,000 JPY
22,940,000 JPY
Net assets
2,006,797,000 JPY
2,531,475,000 JPY
Liabilities and net assets
2,117,347,000 JPY
2,771,202,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.